TF-TAVR using 20mm SAPIEN S3 Ultra Valve in a Centenarian Patient

104 year-old-female with cardiomyopathy, kyphoscoliosis, pleural effusion s/p thoracentesis, NSVT now presents with progressive exertional dyspnea (NYHA Class III) for few months. Patient underwent urgent balloon aortic valvuloplasty in August 2020 in setting of acute congestive heart failure and severe aortic stenosis. Recent transthoracic echocardiogram revealed LVEF of 35% and severe calcified aortic stenosis with AVA/PG/MG/PV of 0.35/74/48/4.3. Recent angiogram revealed non-obstructive CAD. CTA showed horizontal aorta with aortic annulus diameter of 18.8 mm X 23.6 mm (mean 21.2 mm), perimeter 66.6 mm and area 342.5 mm2. Her STS Risk for surgical AVR was 6.89%. Heart Team evaluation found her to be appropriate for TAVR despite advanced age. Analysis of lower extremity on CTA revealed severely calcified peripheral artery disease with diameter less than 5.5mm in b/l common iliac arteries. Now planned for TF-TAVR using 20mm SAPIEN S3 Ultra valve via left femoral percutaneous access with PTA of left common iliac artery.


Published

January 12, 2021

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Samin K. Sharma, MD

Samin K. Sharma, MD

Director, Mount Sinai Cardiovascular Clinical Institute
Director, Interventional Cardiology, Mount Sinai Health System
President, Mount Sinai Fuster Heart Hospital Network
Anandi Lal Sharma Professor of Medicine (Cardiology)

View full profile

Annapoorna Kini, MD

Annapoorna Kini, MD

Director, Cardiac Catheterization Lab
Director, Interventional Structural Heart Disease Program
Director, Interventional Cardiology Fellowship Program
Zena and Michael A. Weiner Professor of Medicine, Cardiology
Mount Sinai Health System

View full profile

Pedro Moreno, MD

Pedro Moreno, MD

Professor, Medicine, Cardiology
Mount Sinai Morningside and Mount Sinai West
The Mount Sinai Hospital

View full profile